ClinicalTrials.gov
ClinicalTrials.gov Menu

Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures (CARDIF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01370044
Recruitment Status : Terminated (results of interim analysis (not safety relevant))
First Posted : June 9, 2011
Last Update Posted : January 26, 2018
Sponsor:
Information provided by (Responsible Party):
Markus Schuelke, M.D., Charite University, Berlin, Germany